• Self-Amplifying RNA for Dose-Sparing Influenza Vaccines

  2026-08-13

  This study shows that self-amplifying RNA can overcome the weak influenza B immunogenicity observed with conventional mRNA vaccination in mice. Its dose-sparing and durability findings support platform-specific optimization of RNA vaccines while also highlighting why nucleoside chemistry, antigen design, and RNA architecture must be evaluated separately.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-08-12

  The Annexin V-FITC/PI Apoptosis Assay Kit provides a practical two-parameter method for separating viable, early apoptotic, and membrane-compromised cells by fluorescence microscopy or flow cytometry. It is intended for research apoptosis assays and should not be used as a standalone diagnostic test or as proof of a specific cell-death pathway.

• EPO mRNA: From Cap 1 Design to SCI Translation

  2026-08-12

  Targeted EPO mRNA delivery is reshaping how researchers approach spinal cord injury, neuroprotection, and erythropoiesis. A 2026 Materials Today Bio study used mannose-modified lipid nanoparticles to localize EPO mRNA to inflammatory macrophages and microglia, reducing ferroptosis-associated injury in mice. This article examines the mechanistic rationale, experimental design, translational limitations, and strategic value of EZ Cap™ EPO mRNA (ψUTP) as a defined RNA input for mammalian protein expression and therapeutic research.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-11

  This study develops a patient-specific gastric cancer assembloid by combining matched tumor organoids with tumor-derived stromal subpopulations. The model reveals that stromal composition alters gene expression and drug sensitivity, creating a more physiologically informative system for investigating tumor–stroma interactions and personalized treatment responses.

• CPI-613: Mitochondrial Metabolism Workflows

  2026-08-11

  Build a reproducible CPI-613 workflow that connects mitochondrial carbon flux, apoptosis, and carefully controlled ferroptosis-related readouts. Practical dosing, orthogonal assays, formulation guidance, and troubleshooting help distinguish target-linked metabolic effects from nonspecific cytotoxicity.

• Trametinib (GSK1120212) Assay Guide

  2026-08-10

  A scenario-based laboratory guide to using Trametinib (GSK1120212), SKU A3018, for MEK-ERK pathway modulation, cell-cycle analysis, and viability studies. It covers stock preparation, assay compatibility, interpretation of cytostasis versus apoptosis, and practical product-selection criteria supported by product data and recent pathway literature.

• Bobcat339 in DNA Methylation Research

  2026-08-09

  Bobcat339 is a cytosine structure-based TET enzyme inhibitor for probing DNA methylation regulation and gene transcription modulation. This article presents an assay-centered framework for applying it to UHRF1-linked osteogenic dysfunction and senile osteoporosis research.

• Rotigotine Workflows for Parkinson’s Disease Research

  2026-08-08

  Rotigotine supports both receptor-focused cell assays and route-resolved Parkinson’s disease models, including lower urinary tract studies. This guide translates published dosing data into practical preparation, cystometry, neuroprotection, and troubleshooting workflows.

• ML133 HCl: A Mechanistic Guide to Kir2.1 Assays

  2026-08-07

  ML133 HCl is a selective potassium channel inhibitor for dissecting Kir2.1-dependent signaling in vascular smooth muscle. This guide connects channel pharmacology with pulmonary remodeling assays, practical controls, and evidence-based interpretation.

• IGF2BP3–FZD1/7 Axis Drives Chemoresistance in TNBC Stem Cell

  2026-08-07

  This study uncovers how IGF2BP3, an m6A reader, stabilizes FZD1/7 transcripts and activates β-catenin signaling in triple-negative breast cancer stem cells, promoting stemness and carboplatin resistance. Targeting this IGF2BP3–FZD1/7 pathway may enhance therapeutic efficacy and reduce chemotherapy dosing in TNBC.

• LY2228820: Advanced Insights into p38 MAP Kinase Inhibition

  2026-08-06

  Explore the scientific depth of LY2228820, a potent p38 MAP kinase inhibitor, including its unique anti-inflammatory and anti-angiogenic applications. This article provides advanced assay guidance and differentiates LY2228820’s value from existing protocols.

• N-MYC/eIF4G1 Axis Controls Survival in inv(16) AML Cells

  2026-08-06

  This study uncovers a previously uncharacterized role for N-MYC in the survival of inv(16) acute myeloid leukemia cells, acting through regulation of the translation initiation factor eIF4G1. The identification of a novel MYCN enhancer and the oncogenic N-MYC/eIF4G1 axis provides new mechanistic insights and potential therapeutic targets for specific AML subtypes.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Immune a

  2026-08-05

  Chlorpromazine HCl, a high-purity dopamine receptor antagonist, is redefining neuropharmacology and infection research by enabling precise control of dopaminergic signaling and cellular defense mechanisms. New studies show its power to modulate macrophage function and neuronal pathways, equipping researchers with a versatile tool for both psychotic disorder modeling and host-pathogen interaction assays.

• Amplex Red: Precision ROS Detection and Redox Assay Workflow

  2026-08-05

  Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) enables ultrasensitive, low-background detection of hydrogen peroxide and peroxidase activity in a wide range of redox biology and cell-based assays. This article decodes advanced workflow optimizations, troubleshooting strategies, and practical insights from recent electrokinetic biosensing innovations to help researchers unlock the full potential of APExBIO’s Amplex Red in both standard and cutting-edge applications.

• Rotavirus Suppresses Nrf2-Dependent Antioxidant Defense: New

  2026-08-04

  This study demonstrates that progressive rotavirus infection robustly downregulates the redox-sensitive transcription factor Nrf2 and its downstream antioxidant genes in vitro. The findings reveal novel mechanisms by which rotavirus evades host cellular stress responses, with broader implications for antiviral strategy development and redox biology.

11762 records 1/785 page Next 12345 下5页 Last page